Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DHA for Lipid and Metabolic Alterations in HIV Patients on HAART
NCT02005900Phase 3Completed
- Sponsor
- Hospital de la Santa Creu i Sant Pau Research Institute
- Start
- Jun 2011
- Primary completion
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of docosahexaenoic acid in hypertriglyceridemia, hypercholesterolemia, lipodystrophy, sponsored by Hospital de la Santa Creu i Sant Pau Research Institute. Started Jun 2011; status: completed.
02
Drugs
docosahexaenoic acid
03
Conditions
hypertriglyceridemiahypercholesterolemialipodystrophy
Beyond the preview
Go deeper on NCT02005900.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02005900.